Recurrent respiratory papillomatosis: update 2018
CS Derkay, AE Bluher - Current opinion in otolaryngology & head …, 2018 - journals.lww.com
RRP is declining in incidence but remains a challenging disease to treat with great costs to
patients, families, and the healthcare system. As the disease continues to be better …
patients, families, and the healthcare system. As the disease continues to be better …
Recurrent respiratory papillomatosis: Update 2018
CS Derkay, AE Bluher - … Opinion in Otolaryngology and Head and …, 2018 - profiles.wustl.edu
Purpose of review Recurrent respiratory papillomatosis (RRP) is the most common as well
as the costliest benign airway neoplasm in the United States [Ivancic et al.(2018) …
as the costliest benign airway neoplasm in the United States [Ivancic et al.(2018) …
Recurrent respiratory papillomatosis: update 2018
CS Derkay, AE Bluher - Current opinion in otolaryngology …, 2018 - pubmed.ncbi.nlm.nih.gov
Purpose of review Recurrent respiratory papillomatosis (RRP) is the most common as well
as the costliest benign airway neoplasm in the United States [Ivancic et al.(2018) …
as the costliest benign airway neoplasm in the United States [Ivancic et al.(2018) …
Recurrent respiratory papillomatosis: update 2018.
CS Derkay, AE Bluher - Current Opinion in Otolaryngology & Head …, 2018 - europepmc.org
RRP is declining in incidence but remains a challenging disease to treat with great costs to
patients, families, and the healthcare system. As the disease continues to be better …
patients, families, and the healthcare system. As the disease continues to be better …